News
Deerfield Management and AWS Team Up on AI-Driven Healthcare, Anchored at NYC’s Cure Campus
Overview
Deerfield Management is a New York investment firm focused on healthcare. It announced a collaboration with Amazon Web Services (AWS) to help build and scale “AI-native” healthcare and life sciences companies, meaning companies designed around AI from the start. The partnership brings together AWS’s generative AI and cloud services,Deerfield’s data, technology and AI team and Cure, Deerfield’s healthcare innovation campus in New York City. Focus areas include:
Drug discovery: AWS tools such as Amazon Bio Discovery, applied to Deerfield’s research and its portfolio companies
Agentic AI for operations: AI agents that can carry out multi-step tasks, built on tools like Amazon Bedrock AgentCore
Care delivery and admin burden: automating clinical and administrative workflows
The Big Picture
AWS programming at Cure gives NYC founders, researchers and companies a nearby place to connect with enterprise AI tools and expertise. That strengthens NYC’s position as a center for health and life sciences innovation. Investors expect AI from day one. With a major healthcare investor formally committing to AI-native companies, founders raising money should expect investors to ask how AI fits into their R&D, operations or care model. Investor-backed AI infrastructure is a growing trend. Investors and cloud providers are packaging tools, training and technical support for their portfolio companies. This can give backed startups an advantage, so other early-stage companies should look at comparable cloud and AI startup programs. The impact goes beyond drug discovery, which opens doors for New York’s digital health and health IT companies, not only biotech.
